A citation-based method for searching scientific literature

Jillian F Wise, Sigve Nakken, Chloé B Steen, Daniel Vodák, Gunhild Trøen, Bjarne Johannessen, Ole Christian Lingjærde, Vera Hilden, Yngvild Nuvin Blaker, Baoyan Bai, Lars Birger Aasheim, Annika Pasanen, Susanne Lorenz, Anita Sveen, Ragnhild A Lothe, Ola Myklebost, Sirpa Leppä, Leonardo A Meza-Zepeda, Klaus Beiske, Michael S Lawrence, Eivind Hovig, June Helen Myklebust, Erlend B Smeland, Harald Holte. Blood Adv 2020
Times Cited: 4







List of co-cited articles
18 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes.
Bjoern Chapuy, Chip Stewart, Andrew J Dunford, Jaegil Kim, Atanas Kamburov, Robert A Redd, Mike S Lawrence, Margaretha G M Roemer, Amy J Li, Marita Ziepert,[...]. Nat Med 2018
447
100

Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.
Anupama Reddy, Jenny Zhang, Nicholas S Davis, Andrea B Moffitt, Cassandra L Love, Alexander Waldrop, Sirpa Leppa, Annika Pasanen, Leo Meriranta, Marja-Liisa Karjalainen-Lindsberg,[...]. Cell 2017
370
75

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.
Roland Schmitz, George W Wright, Da Wei Huang, Calvin A Johnson, James D Phelan, James Q Wang, Sandrine Roulland, Monica Kasbekar, Ryan M Young, Arthur L Shaffer,[...]. N Engl J Med 2018
540
75

Genetic Landscapes of Relapsed and Refractory Diffuse Large B-Cell Lymphomas.
Ryan D Morin, Sarit Assouline, Miguel Alcaide, Arezoo Mohajeri, Rebecca L Johnston, Lauren Chong, Jasleen Grewal, Stephen Yu, Daniel Fornika, Kevin Bushell,[...]. Clin Cancer Res 2016
108
75

Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study.
Stephen M Ansell, Monique C Minnema, Peter Johnson, John M Timmerman, Philippe Armand, Margaret A Shipp, Scott J Rodig, Azra H Ligon, Margaretha G M Roemer, Nishitha Reddy,[...]. J Clin Oncol 2019
110
75

Combined genetic inactivation of β2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma.
Madhavi Challa-Malladi, Yen K Lieu, Olivia Califano, Antony B Holmes, Govind Bhagat, Vundavalli V Murty, David Dominguez-Sola, Laura Pasqualucci, Riccardo Dalla-Favera. Cancer Cell 2011
247
75

Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing.
Jens G Lohr, Petar Stojanov, Michael S Lawrence, Daniel Auclair, Bjoern Chapuy, Carrie Sougnez, Peter Cruz-Gordillo, Birgit Knoechel, Yan W Asmann, Susan L Slager,[...]. Proc Natl Acad Sci U S A 2012
639
50

Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte.
Bertrand Coiffier, Catherine Thieblemont, Eric Van Den Neste, Gérard Lepeu, Isabelle Plantier, Sylvie Castaigne, Sophie Lefort, Gérald Marit, Margaret Macro, Catherine Sebban,[...]. Blood 2010
798
50

Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclones.
Thomas Melchardt, Clemens Hufnagl, David M Weinstock, Nadja Kopp, Daniel Neureiter, Wolfgang Tränkenschuh, Hubert Hackl, Lukas Weiss, Gabriel Rinnerthaler, Tanja N Hartmann,[...]. Oncotarget 2016
26
50

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.
A A Alizadeh, M B Eisen, R E Davis, C Ma, I S Lossos, A Rosenwald, J C Boldrick, H Sabet, T Tran, X Yu,[...]. Nature 2000
50

Diffuse large B-cell lymphomas with CDKN2A deletion have a distinct gene expression signature and a poor prognosis under R-CHOP treatment: a GELA study.
Fabrice Jardin, Jean-Philippe Jais, Thierry-Jo Molina, Françoise Parmentier, Jean-Michel Picquenot, Philippe Ruminy, Hervé Tilly, Christian Bastard, Gilles-André Salles, Pierre Feugier,[...]. Blood 2010
80
50

Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples.
Kristian Cibulskis, Michael S Lawrence, Scott L Carter, Andrey Sivachenko, David Jaffe, Carrie Sougnez, Stacey Gabriel, Matthew Meyerson, Eric S Lander, Gad Getz. Nat Biotechnol 2013
50

Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL.
Ziju Y Xu-Monette, Min Xiao, Qingyan Au, Raghav Padmanabhan, Bing Xu, Nicholas Hoe, Sandra Rodríguez-Perales, Raul Torres-Ruiz, Ganiraju C Manyam, Carlo Visco,[...]. Cancer Immunol Res 2019
38
50

Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study.
Michael Crump, Sattva S Neelapu, Umar Farooq, Eric Van Den Neste, John Kuruvilla, Jason Westin, Brian K Link, Annette Hay, James R Cerhan, Liting Zhu,[...]. Blood 2017
434
50

PD-1 expression and clinical PD-1 blockade in B-cell lymphomas.
Zijun Y Xu-Monette, Jianfeng Zhou, Ken H Young. Blood 2018
159
50

A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications.
George W Wright, Da Wei Huang, James D Phelan, Zana A Coulibaly, Sandrine Roulland, Ryan M Young, James Q Wang, Roland Schmitz, Ryan D Morin, Jeffrey Tang,[...]. Cancer Cell 2020
87
50

Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.
Sattva S Neelapu, Frederick L Locke, Nancy L Bartlett, Lazaros J Lekakis, David B Miklos, Caron A Jacobson, Ira Braunschweig, Olalekan O Oluwole, Tanya Siddiqi, Yi Lin,[...]. N Engl J Med 2017
50

Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma.
Christopher K Rushton, Sarah E Arthur, Miguel Alcaide, Matthew Cheung, Aixiang Jiang, Krysta M Coyle, Kirstie L S Cleary, Nicole Thomas, Laura K Hilton, Neil Michaud,[...]. Blood Adv 2020
12
50

Recurrent targets of aberrant somatic hypermutation in lymphoma.
Alireza Hadj Khodabakhshi, Ryan D Morin, Anthony P Fejes, Andrew J Mungall, Karen L Mungall, Madison Bolger-Munro, Nathalie A Johnson, Joseph M Connors, Randy D Gascoyne, Marco A Marra,[...]. Oncotarget 2012
86
25

p16INK4a and p14ARF tumor suppressor genes are commonly inactivated in cutaneous squamous cell carcinoma.
Victoria L Brown, Catherine A Harwood, Tim Crook, James G Cronin, David P Kelsell, Charlotte M Proby. J Invest Dermatol 2004
100
25


Collaboration of pim-1 and bcl-2 in lymphomagenesis.
D Acton, J Domen, H Jacobs, M Vlaar, S Korsmeyer, A Berns. Curr Top Microbiol Immunol 1992
33
25

The mutational constraint spectrum quantified from variation in 141,456 humans.
Konrad J Karczewski, Laurent C Francioli, Grace Tiao, Beryl B Cummings, Jessica Alföldi, Qingbo Wang, Ryan L Collins, Kristen M Laricchia, Andrea Ganna, Daniel P Birnbaum,[...]. Nature 2020
25


Pim-1 kinase inhibits STAT5-dependent transcription via its interactions with SOCS1 and SOCS3.
Katriina J Peltola, Kirsi Paukku, Teija L T Aho, Marja Ruuska, Olli Silvennoinen, Päivi J Koskinen. Blood 2004
85
25

Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway.
J P Rouault, N Falette, F Guéhenneux, C Guillot, R Rimokh, Q Wang, C Berthet, C Moyret-Lalle, P Savatier, B Pain,[...]. Nat Genet 1996
330
25

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP.
Laurie H Sehn, Brian Berry, Mukesh Chhanabhai, Catherine Fitzgerald, Karamjit Gill, Paul Hoskins, Richard Klasa, Kerry J Savage, Tamara Shenkier, Judy Sutherland,[...]. Blood 2007
832
25

Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies.
Kian-Huat Lim, Yibin Yang, Louis M Staudt. Immunol Rev 2012
109
25


Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas.
L Pasqualucci, P Neumeister, T Goossens, G Nanjangud, R S Chaganti, R Küppers, R Dalla-Favera. Nature 2001
736
25

COSMIC: the Catalogue Of Somatic Mutations In Cancer.
John G Tate, Sally Bamford, Harry C Jubb, Zbyslaw Sondka, David M Beare, Nidhi Bindal, Harry Boutselakis, Charlotte G Cole, Celestino Creatore, Elisabeth Dawson,[...]. Nucleic Acids Res 2019
934
25

Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets.
K Karube, A Enjuanes, I Dlouhy, P Jares, D Martin-Garcia, F Nadeu, G R Ordóñez, J Rovira, G Clot, C Royo,[...]. Leukemia 2018
61
25

Tumor suppressors BTG1 and BTG2: Beyond growth control.
Laurensia Yuniati, Blanca Scheijen, Laurens T van der Meer, Frank N van Leeuwen. J Cell Physiol 2019
49
25

Mutational Evolution in Relapsed Diffuse Large B-Cell Lymphoma.
Marcel Nijland, Annika Seitz, Martijn Terpstra, Gustaaf W van Imhoff, Philip M Kluin, Tom van Meerten, Çiğdem Atayar, Léon C van Kempen, Arjan Diepstra, Klaas Kok,[...]. Cancers (Basel) 2018
9
25

LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets.
Andreas Wilm, Pauline Poh Kim Aw, Denis Bertrand, Grace Hui Ting Yeo, Swee Hoe Ong, Chang Hua Wong, Chiea Chuen Khor, Rosemary Petric, Martin Lloyd Hibberd, Niranjan Nagarajan. Nucleic Acids Res 2012
489
25

Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium.
Andreas Rosenwald, Susanne Bens, Ranjana Advani, Sharon Barrans, Christiane Copie-Bergman, Mad-Helenie Elsensohn, Yaso Natkunam, Maria Calaminici, Birgitta Sander, Maryse Baia,[...]. J Clin Oncol 2019
44
25

Exome sequencing reveals novel mutation targets in diffuse large B-cell lymphomas derived from Chinese patients.
Noel F C C de Miranda, Konstantinos Georgiou, Longyun Chen, Chenglin Wu, Zhibo Gao, Apostolos Zaravinos, Susana Lisboa, Gunilla Enblad, Manuel R Teixeira, Yixin Zeng,[...]. Blood 2014
71
25

Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels.
Daisuke Morishita, Ryohei Katayama, Kazuhisa Sekimizu, Takashi Tsuruo, Naoya Fujita. Cancer Res 2008
203
25

Clinicopathologic significance of MYD88 L265P mutation in diffuse large B-cell lymphoma: a meta-analysis.
Ju-Han Lee, Hoiseon Jeong, Jung-Woo Choi, HwaEun Oh, Young-Sik Kim. Sci Rep 2017
39
25

Activation of NF-κB in B cell receptor signaling through Bruton's tyrosine kinase-dependent phosphorylation of IκB-α.
Marilena Pontoriero, Giuseppe Fiume, Eleonora Vecchio, Annamaria de Laurentiis, Francesco Albano, Enrico Iaccino, Selena Mimmi, Antonio Pisano, Valter Agosti, Emilia Giovannone,[...]. J Mol Med (Berl) 2019
20
25

Human ARF protein interacts with topoisomerase I and stimulates its activity.
L Karayan, J F Riou, P Séité, J Migeon, A Cantereau, C J Larsen. Oncogene 2001
73
25

A bioclinical prognostic model using MYC and BCL2 predicts outcome in relapsed/refractory diffuse large B-cell lymphoma.
Mark Bosch, Ariz Akhter, Bingshu E Chen, Adnan Mansoor, David Lebrun, David Good, Michael Crump, Lois Shepherd, David W Scott, Douglas A Stewart. Haematologica 2018
9
25

Pim-1 controls NF-kappaB signalling by stabilizing RelA/p65.
K Nihira, Y Ando, T Yamaguchi, Y Kagami, Y Miki, K Yoshida. Cell Death Differ 2010
81
25

Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/07 prospective clinical trial cohort.
Darius Juskevicius, David Jucker, Dirk Klingbiel, Christoph Mamot, Stephan Dirnhofer, Alexandar Tzankov. J Hematol Oncol 2017
34
25

Role of p53 and CDKN2A inactivation in human squamous cell carcinomas.
Alessia Pacifico, Giovanni Leone. J Biomed Biotechnol 2007
18
25

Phosphorylation of the cell cycle inhibitor p21Cip1/WAF1 by Pim-1 kinase.
Zeping Wang, Nandini Bhattacharya, Philip F Mixter, Wenyi Wei, John Sedivy, Nancy S Magnuson. Biochim Biophys Acta 2002
159
25


Relapsed/refractory diffuse large B-cell lymphoma.
Jonathan W Friedberg. Hematology Am Soc Hematol Educ Program 2011
271
25

How I manage patients with relapsed/refractory diffuse large B cell lymphoma.
Christian Gisselbrecht, Eric Van Den Neste. Br J Haematol 2018
53
25

Pim-1 kinase promotes inactivation of the pro-apoptotic Bad protein by phosphorylating it on the Ser112 gatekeeper site.
Teija L T Aho, Jouko Sandholm, Katriina J Peltola, Harri P Mankonen, Michael Lilly, Päivi J Koskinen. FEBS Lett 2004
260
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.